Top

Published in:

01-10-2018 | Original Article

Two-Dimensional Speckle Tracking Echocardiography-Derived Strain Measurements in Survivors of Childhood Cancer on Angiotensin Converting Enzyme Inhibition or Receptor Blockade

Authors: Jamie K. Harrington, Marc E. Richmond, Arielle W. Fein, Serge Kobsa, Prakash Satwani, Amee Shah

Published in: Pediatric Cardiology | Issue 7/2018

Abstract

Speckle tracking echocardiography (STE)-derived strain indices are believed to detect early cardiac dysfunction in survivors of childhood cancer and have potential to identify patients who may benefit from early heart failure treatment. However, effects of heart failure treatment on STE-derived strain measurements in this population are unknown. The aim of this study was to assess STE-derived strain measurements in survivors of childhood cancer treated with angiotensin converting enzyme inhibition or receptor blockade (ACEi/ARB). Two-dimensional speckle tracking analysis was retrospectively performed on echocardiograms from childhood cancer survivors before and during therapy with ACEi/ARB. Global left ventricular longitudinal and circumferential strain (GLS and GCS) and strain rates (LSR and CSR) were assessed and correlated with conventional echocardiographic measures of function. In 22 childhood cancer survivors (median age: 14.8, range 6.4–21.6 years), mean GLS (− 13.83 ± 0.74% to − 15.94 ± 0.74%, p = 0.002), GCS (− 18.79 ± 1.21% to − 20.74 ± 0.84%, p = 0.027), LSR (− 0.78 ± 0.04 to − 0.88 ± 0.04 s⁻¹, p = 0.022), and CSR (− 1.08 ± 0.07 to − 1.21 ± 0.06 s⁻¹, p = 0.027) improved on therapy. Improvement in GLS was maintained for greater than 1 year on ACEi/ARB (p = 0.02). Measures of strain and strain rate correlated with standard echocardiographic measures of function and were reproducible. These findings support the use of ACEi/ARB to treat post-chemotherapy-related cardiovascular changes in childhood cancer survivors, provide proof-of-concept that STE-derived strain and strain rate may be used to reliably monitor cardiac function during therapy, and support continued investigation into the clinical benefit of strain measurements in this population.

Howlander N, Noone A, Krapcho M (2014) SEER cancer statistics, review, 1975–2010. National Cancer Institute, Bethesda

Armstrong GT, Ross JD (2014) Late cardiotoxicity in aging adult survivors of childhood cancer. Prog Pediatr Cardiol 36:19–26. https://doi.org/10.1016/j.ppedcard.2014.09.003 CrossRefPubMedPubMedCentral

Armstrong GT, Kawashima T, Leisenring W et al (2014) Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol 32:1218–1227. https://doi.org/10.1200/JCO.2013.51.1055 CrossRefPubMedPubMedCentral

Hochberg JC, Cairo MS, Friedman DM (2014) Cardio-oncology issues among pediatric cancer and stem cell transplant survivors. Cardiol Rev 22:268–274. https://doi.org/10.1097/CRD.0000000000000030 CrossRefPubMed

Oeffinger KC, Mertens AC, Sklar CA et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572–1582. https://doi.org/10.1056/NEJMsa060185 CrossRefPubMed

Landier W, Bhatia S, Eshelman DA et al (2004) Development of risk-based guidelines for pediatric cancer survivors: the children’s oncology group long-term follow-up guidelines from the children’s oncology group late effects committee and nursing discipline. J Clin Oncol 22:4979–4990. https://doi.org/10.1200/JCO.2004.11.032 CrossRefPubMed

Wong FL, Bhatia S, Landier W et al (2014) Cost-effectiveness of the children’s oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure. Ann Intern Med 160:672. https://doi.org/10.7326/M13-2498 CrossRefPubMedPubMedCentral

Curigliano G, Cardinale D, Suter T et al (2012) Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines. Ann Oncol 23:vii155-vii166. https://doi.org/10.1093/annonc/mds293 CrossRef

Eschenhagen T, Force T, Ewer MS et al (2011) Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 13:1–10. https://doi.org/10.1093/eurjhf/hfq213 CrossRefPubMed

10.

Children’s Oncology Group. http://www.survivorshipguidelines.org/. Accessed 19 Apr 2017

11.

Groarke JD, Nohria A, Middleman E et al (2015) Anthracycline cardiotoxicity: a new paradigm for an old classic. Circulation 131:1946–1949. https://doi.org/10.1161/CIRCULATIONAHA.115.016704 CrossRefPubMed

12.

Harake D, Franco VI, Henkel JM et al (2012) Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future Cardiol 8:647–670. https://doi.org/10.2217/fca.12.44 CrossRefPubMed

13.

Lipshultz SE, Cochran TR, Franco VI, Miller TL (2013) Treatment-related cardiotoxicity in survivors of childhood cancer. Nat Rev Clin Oncol 10:697–710. https://doi.org/10.1038/nrclinonc.2013.195 CrossRefPubMed

14.

Lipshultz SE, Karnik R, Sambatakos P et al (2014) Anthracycline-related cardiotoxicity in childhood cancer survivors. Curr Opin Cardiol 29:103–112. https://doi.org/10.1097/HCO.0000000000000034 CrossRefPubMed

15.

Lipshultz SE, Miller TL, Scully RE et al (2012) Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. J Clin Oncol 30:1042–1049. https://doi.org/10.1200/JCO.2010.30.3404 CrossRefPubMedPubMedCentral

16.

Dandel M, Lehmkuhl H, Knosalla C et al (2009) Strain and strain rate imaging by echocardiography: basic concepts and clinical applicability. Curr Cardiol Rev 5:133–148. https://doi.org/10.2174/157340309788166642 CrossRefPubMedPubMedCentral

17.

Bansal M, Kasliwal RR (2013) How do I do it? Speckle-tracking echocardiography. Indian Heart J 65:117–123. https://doi.org/10.1016/j.ihj.2012.12.004 CrossRefPubMedPubMedCentral

18.

Thavendiranathan P, Poulin F, Lim K-D et al (2014) Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol 63:2751–2768. https://doi.org/10.1016/j.jacc.2014.01.073 CrossRefPubMed

19.

Dessì M, Piras A, Madeddu C et al (2011) Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction. Exp Ther Med 2:1003–1009. https://doi.org/10.3892/etm.2011.305 CrossRefPubMedPubMedCentral

20.

Dessì M, Madeddu C, Piras A et al (2013) Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate. Springerplus 2:198. https://doi.org/10.1186/2193-1801-2-198 CrossRefPubMedPubMedCentral

21.

Cardinale D, Colombo A, Bacchiani G et al (2015) Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation 131:1981–1988. https://doi.org/10.1161/CIRCULATIONAHA.114.013777 CrossRefPubMed

22.

Cardinale D, Colombo A, Sandri MT et al (2006) Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation 114:2474–2481. https://doi.org/10.1161/CIRCULATIONAHA.106.635144 CrossRefPubMed

23.

Janbabai G, Nabati M, Faghihinia M et al (2016) Effect of enalapril on preventing anthracycline-induced cardiomyopathy. Cardiovasc Toxicol. https://doi.org/10.1007/s12012-016-9365-z CrossRef

24.

Lopez L, Colan SD, Frommelt PC et al (2010) Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr 23:465–495. https://doi.org/10.1016/j.echo.2010.03.019 CrossRefPubMed

25.

Lai WW, Geva T, Shirali GS et al (2006) Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr 19:1413–1430. https://doi.org/10.1016/j.echo.2006.09.001 CrossRefPubMed

26.

Sawaya H, Sebag IA, Plana JC et al (2012) Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging 5:596–603. https://doi.org/10.1161/CIRCIMAGING.112.973321 CrossRefPubMedPubMedCentral

27.

Sawaya H, Sebag IA, Plana JC et al (2011) Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol 107:1375–1380. https://doi.org/10.1016/j.amjcard.2011.01.006 CrossRefPubMedPubMedCentral

28.

Mornoş C, Petrescu L (2013) Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist. Can J Physiol Pharmacol 91:601–607. https://doi.org/10.1139/cjpp-2012-0398 CrossRefPubMed

29.

Negishi K, Negishi T, Hare JL et al (2013) Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr 26:493–498. https://doi.org/10.1016/j.echo.2013.02.008 CrossRefPubMed

30.

Negishi K, Negishi T, Haluska BA et al (2014) Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection. Eur Heart J Cardiovasc Imaging 15:324–331. https://doi.org/10.1093/ehjci/jet159 CrossRefPubMed

31.

Baratta S, Damiano MA, Marchese ML et al (2013) Serum markers, conventional doppler echocardiography and two-dimensional systolic strain in the diagnosis of chemotherapy-induced myocardial toxicity. Argent J Cardiol 81:133–138. https://doi.org/10.7775/AJC.81.2.2300 CrossRef

32.

Plana JC, Galderisi M, Barac A et al (2014) Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 27:911–939. https://doi.org/10.1016/j.echo.2014.07.012 CrossRefPubMed

33.

Poterucha JT, Kutty S, Lindquist RK et al (2012) Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction. J Am Soc Echocardiogr 25:733–740. https://doi.org/10.1016/j.echo.2012.04.007 CrossRefPubMed

34.

Moon TJ, Miyamoto SD, Younoszai AK, Landeck BF (2014) Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy. Cardiol Young 24:854–865. https://doi.org/10.1017/S1047951113001182 CrossRefPubMed

35.

Lipshultz SE, Lipsitz SR, Sallan SE et al (2002) Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol 20:4517–4522. https://doi.org/10.1200/JCO.2002.12.102 CrossRefPubMed

36.

Silber JH, Cnaan A, Clark BJ et al (2004) Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol 22:820–828. https://doi.org/10.1200/JCO.2004.06.022 CrossRefPubMed

Title: Two-Dimensional Speckle Tracking Echocardiography-Derived Strain Measurements in Survivors of Childhood Cancer on Angiotensin Converting Enzyme Inhibition or Receptor Blockade
Authors: Jamie K. Harrington
Marc E. Richmond
Arielle W. Fein
Serge Kobsa
Prakash Satwani
Amee Shah
Publication date: 01-10-2018
Publisher: Springer US
Published in: Pediatric Cardiology / Issue 7/2018
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-018-1910-z

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Two-Dimensional Speckle Tracking Echocardiography-Derived Strain Measurements in Survivors of Childhood Cancer on Angiotensin Converting Enzyme Inhibition or Receptor Blockade

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2018

Predictors of Rapid Aortic Root Dilation and Referral for Aortic Surgery in Marfan Syndrome

Comparison of Clinical Profiles in Patients with Protein-Losing Enteropathy With and Without Fontan Circulation

Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation

Catheter, MRI and CT Imaging in Newborns with Pulmonary Atresia with Ventricular Septal Defect and Aortopulmonary Collaterals: Quantifying the Risks of Radiation Dose and Anaesthetic Time

Neonatal Myocardial Perfusion in Right Ventricle Dependent Coronary Circulation: Clinical Surrogates and Role of Troponin-I in Postoperative Management Following Systemic-to-Pulmonary Shunt Physiology

Transcatheter Intervention of Coronary Obstructions in Infants, Children, and Young Adults

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page